4.8 Editorial Material

Sources of Innovation in Gene Therapies - Approaches to Achieving Affordable Prices

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Rapid manufacturing of non-activated potent CAR T cells

Saba Ghassemi et al.

Summary: Non-activated CAR T cells can be generated within 24 hours from T cells derived from peripheral blood, without the need for T-cell activation. This rapid manufacturing method has the potential to reduce production costs and broaden the applicability of CAR T cells.

NATURE BIOMEDICAL ENGINEERING (2022)

Editorial Material Biochemistry & Molecular Biology

Adverse effects of acquisitions in the pharmaceutical industry

Melissa Newham et al.

Summary: Publicly funded research contributes to the development of new drugs, but the profits are primarily obtained by big pharmaceutical companies through exclusive licensing deals, mergers, and acquisitions, which can lead to decreased competition and limited access to medicines for patients.

NATURE MEDICINE (2022)

Review Medicine, General & Internal

Gene Therapy

Katherine A. High et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)